16786535

Source:http://linkedlifedata.com/resource/pubmed/id/16786535

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0004364, umls-concept:C0006104, umls-concept:C1555029
pubmed:issue	3
pubmed:dateCreated	2006-9-25
pubmed:abstractText	To assess the immunomodulatory activity of methylthioadenosine (MTA) in rodent experimental autoimmune encephalomyelitis (EAE) and in patients with multiple sclerosis.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7707449
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Amyloid beta-Protein Precursor, http://linkedlifedata.com/resource/pubmed/chemical/Cytokines, http://linkedlifedata.com/resource/pubmed/chemical/Immunologic Factors, http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase Type II, http://linkedlifedata.com/resource/pubmed/chemical/Phytohemagglutinins, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Thionucleosides
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	0364-5134
pubmed:author	pubmed-author:AvilaMatias AMA, pubmed-author:BerasainCarmenC, pubmed-author:CorralesFernando JFJ, pubmed-author:García-TrevijanoElena RER, pubmed-author:MorenoBeatrizB, pubmed-author:MuñozJavierJ, pubmed-author:SantamariaMonicaM, pubmed-author:SepulcreJorgeJ, pubmed-author:VillosladaPabloP, pubmed-author:YihR YRY
pubmed:issnType	Print
pubmed:volume	60
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	323-34
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:16786535-Adult, pubmed-meshheading:16786535-Age of Onset, pubmed-meshheading:16786535-Amyloid beta-Protein Precursor, pubmed-meshheading:16786535-Animals, pubmed-meshheading:16786535-Cytokines, pubmed-meshheading:16786535-Disease Models, Animal, pubmed-meshheading:16786535-Dose-Response Relationship, Drug, pubmed-meshheading:16786535-Drug Interactions, pubmed-meshheading:16786535-Encephalomyelitis, Autoimmune, Experimental, pubmed-meshheading:16786535-Female, pubmed-meshheading:16786535-Humans, pubmed-meshheading:16786535-Immunologic Factors, pubmed-meshheading:16786535-Lymphocytes, pubmed-meshheading:16786535-Macrophages, pubmed-meshheading:16786535-Male, pubmed-meshheading:16786535-Middle Aged, pubmed-meshheading:16786535-Multiple Sclerosis, pubmed-meshheading:16786535-Nitric Oxide Synthase Type II, pubmed-meshheading:16786535-Phytohemagglutinins, pubmed-meshheading:16786535-RNA, Messenger, pubmed-meshheading:16786535-Rats, pubmed-meshheading:16786535-Rats, Inbred Lew, pubmed-meshheading:16786535-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:16786535-Statistics, Nonparametric, pubmed-meshheading:16786535-Thionucleosides
pubmed:year	2006
pubmed:articleTitle	Methylthioadenosine reverses brain autoimmune disease.
pubmed:affiliation	Neuroscience and Gene Therapy Division, Center for Applied Medical Research, University of Navarra, Navarra, Spain.
pubmed:publicationType	Journal Article, Comparative Study, Controlled Clinical Trial, Research Support, Non-U.S. Gov't